It was reported that the unit made an unusual sound during use after a "device defective" error message was displayed.The cardiohelp and hls set were replaced during treatment.A getinge service technician investigated the unit on (b)(6) 2021 and could not duplicate the failure.The technician performed safety, calibration, and functionality checks to factory specifications.For further investigation the involved hls set was technically investigated in the getinge laboratory on (b)(6) 2021.Heavy clotting in the oxygenator and especially in the centrifugal pump was noted.The clots could not be removed complete.During function testing of the pump an imbalance and unusual noise could be observed caused by the clots.The log files of the cardiohelp unit were analysed by getinge life cycle engineering for the reported event time.The error message "device defective" could be confirmed.This error is as result of differences between the set and real flow.This could be caused by the clots confirmed in the laboratory investigation of the hls set.Based on the investigation results the reported failures "device defective error message" and "unusual sound" could be confirmed but no product related malfunction.The most probable root cause was determined as heavy clotting disturbing the centrifugal pump.With reference to the risk assessment of the associated hls set (hls set advanced 5.0 / hls set advanced 7.0, dms # 1468452, v26) and in consultation with the getinge manager medical affairs team the following events can contribute to clotting in the circuit: -air remains in or enters the circuit - inappropriately low, or no blood flow, in the circuit -improper hemostasis -too low anticoagulation -too low act level, effect of heparin is too limited -protamine sulfate enters the hls set -administration of congealable substances (such as platelets) or pro-coagulant medications.-(consumption) coagulopathy the occurrence rate was calculated for the reported failure and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿ s trending program and additional investigations or corrections will be implemented in case of adverse trending.
|